20111 results for «»
20111 results
Heterotopic tricuspid valves: to who, when and how?
15 May 2024 – From EuroPCR 2024
Watch this session to gain comprehensive insights into the use, safety, and efficacy of heterotopic tricuspid valves. Learn to identify ideal candidates with severe tricuspid regurgitation, understand key procedural factors for successful implantation, and receive tips on valve systems and anatomy. The session also includes...
Clinical experience with DurAVR THV: a new class, biomimetic TAVI
16 May 2024 – From EuroPCR 2024
Join Azeem Latib, Christopher Meduri, and Nicolas Van Mieghem as they explore the history of cutting-edge tissue science in the TAVI space. Learn about the development of a biomimetic aortic valve design and insights from the DurAVR FIH study on this balloon-expandable platform. Discover the link...
First clinical evidence from a new transcatheter solution utilizing cross-caval anchoring for untreatable TR
16 May 2024 – From EuroPCR 2024
Join Philipp Lurz and Rodrigo Estevez Loureiro as they discuss with Marta Sitges a groundbreaking treatment for tricuspid regurgitation involving the implantation of heterotopic prostheses. They emphasize the harmful effects of backward failure, describe the innovative cross-caval approach, and introduce the Trillium™ and Unica™ devices. This...
Sensor-Guided TAVI using the SavvyWire Pre-Shaped Pressure Guidewire
16 May 2024 – From EuroPCR 2024
In this roundtable discussion, Ole De Backer and Danny Dvir explore the potential of the new SavvyWire to enhance #TAVI procedures by improving safety and efficiency while reducing the need for multiple manipulations. They also highlight how real-time left ventricle monitoring during procedures can lead to...
How will the SMART trial results impact our practice and decision making in TAVI?
16 May 2024 – From EuroPCR 2024
Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....
Coronary interventions: Highlights of EuroPCR 2024
16 May 2024 – From EuroPCR 2024
In this video, Thomas Cuisset and Davide Capodanno discuss with Dejan Milasinovic key moments in coronary intervention at EuroPCR 2024. They highlight innovations in intravascular imaging education, featuring the Imaging Learning Center and its hands-on workstations, and key studies like DOCTOR-LM, following in the footsteps of OCTOBER or BIFURCATION. Educating...
MitraClip Asian experience: clinical evidence and experience in challenging anatomies
15 May 2024 – From EuroPCR 2024
Watch this session to gain insights into the clinical evidence of mitral TEER therapy for the Asian population, learn techniques for implanting a MitraClip in patients with challenging anatomy, and understand how to use the four clip sizes for optimal outcomes. The session also covers educational...
EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years
14 May 2024
Rajiv Das
Evolution of complex PCI: cross, modify it, and be precise!
14 May 2024 – From EuroPCR 2024
Don't miss this session for expert guidance on preparing and managing complex lesions. Gain insights into choosing the right tools, including microcatheters and balloons, for optimal treatment outcomes. Explore the innovative features of flagship devices for complex PCI, and Pronavi microcatheter and Alveo HP CTO balloon...
Amila Premawardhana
lmaging: The eyes of the Heart Team
14 May 2024
More than ever, Heart Team members rely on advanced imaging to guide procedures and aid in decision-making about patient selection and management. Just as imaging plays a prominent role in the cathlab, so it will be central to this year's EuroPCR content, with a track of specially...
Dennis McWilliams
United States of America
EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES
14 May 2024
Supraflex Cruz - Improving patient outcomes: from simple to complex patients
14 May 2024 – From EuroPCR 2024
Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...
Best moments from EuroPCR 2023: relive an unforgettable experience
QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab
15 May 2024 – From EuroPCR 2024
Join this session to delve into the cutting-edge capabilities of the newest QFR technology, allowing for rapid coronary vessel analysis in under 30 seconds. Gain insight into the diagnostic potential of QFR-IMR for assessing coronary microvascular dysfunction and understand its implications for patient care. Explore the...
#EuroPCR 2023 – Best of the first day in Paris
Case closed: understanding the steps of vascular access and closure in TAVI patients
14 May 2024 – From EuroPCR 2024
Join this session to gain comprehensive insights on combining CT and echo guidance for optimal vascular access. Learn detailed steps for vascular closure using suture-mediated devices and explore the challenges and solutions associated with achieving successful suture-mediated vessel closure. This session will provide valuable knowledge and...
EuroPCR 2023 - Best of Day 2
